Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sponsors' Failure To Complete Phase IV Studies Should Draw Penalties - HRG

Executive Summary

Public Citizen's Health Research Group is calling for FDA to seek authority to levy money penalties in cases where sponsors have failed to complete postmarketing studies requested by the agency.

You may also be interested in...



CBER Retooling Application Database: Could Improve Post Approval Tracking

The Center for Biologics Evaluation & Research is implementing a new application database that is expected to improve its ability to keep track of post-marketing commitments and changes to applications.

CBER Retooling Application Database: Could Improve Post Approval Tracking

The Center for Biologics Evaluation & Research is implementing a new application database that is expected to improve its ability to keep track of post-marketing commitments and changes to applications.

CROs Counting On Biotech Stock Rise, Phase IV Trials To Drive New Business

Recently enriched biotechnology companies will help the contract research organization market recover from its slump in the coming year, PPD CEO Fred Eshelman, MD, told analysts during an April 20 conference call.

Related Content

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel